TCM
AMED

Tekla Capital Management’s Amedisys AMED Stock Holding History

Tekla Capital Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-68,949
Closed -$5.07M – 169
2023
Q1 		$5.07M Buy
+68,949
New +$5.97M 0.19% 81
2021
Q3 		– Sell
-48,070
Closed -$11.8M – 175
2021
Q2 		$11.8M Buy
48,070
+28,675
+148% +$7.52M 0.38% 69
2021
Q1 		$5.14M Hold
19,395
– – 0.18% 116
2020
Q4 		$5.69M Hold
19,395
– – 0.2% 112
2020
Q3 		$4.59M Hold
19,395
– – 0.17% 108
2020
Q2 		$3.85M Buy
+19,395
New +$3.62M 0.15% 114

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Tekla Capital Management's AMED Position: Q2 2023 in Review

Tekla Capital Management sold out of Amedisys (AMED) in Q2 2023, closing a stake of 68,949 shares — an estimated $5.07M sold.

Tekla Capital Management first reported a position in AMED in Q2 2020 and held it in 6 quarters. The position peaked at $11.8M in Q2 2021. 302 funds tracked by Wall St. Rank hold AMED as of Q2 2023.

  • Tekla Capital Management reported no remaining Amedisys position as of Q2 2023 after selling out during the quarter.
  • Tekla Capital Management sold 68,949 Amedisys shares in Q2 2023, an estimated $5.07M.
  • Tekla Capital Management first reported a position in Amedisys in Q2 2020 and held it in 6 quarters.
  • Tekla Capital Management's Amedisys position peaked at $11.8M in Q2 2021.
  • 302 funds tracked by Wall St. Rank held Amedisys as of Q2 2023.

Based on Tekla Capital Management's 13F filing for Q2 2023, filed 10 Aug 2023.